Katarzyna Tomaszewska

Dr. Katarzyna Tomaszewska

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KTKatarzyna Tomaszewska
Katarzyna Tomaszewska
MKMagdalena Kozłowska
Magdalena Kozłowska
AKAndrzej Kaszuba
Andrzej Kaszuba
ALAleksandra Lesiak
Aleksandra Lesiak
JNJoanna Narbutt
Joanna Narbutt
AZAnna Zalewska-Janowska
Anna Zalewska-Janowska
Alopecia areata (AA) and vitiligo are both common skin diseases of autoimmune origin. Both alopecia areata and vitiligo have shown to be affected by oxidative stress. The present work is aimed at evaluating and comparing the serum proinflammatory cytokine levels in AA and nonsegmental vitiligo (NSV). A cross-sectional study was conducted of 33 patients with AA, 30 patients with NSV, and 30 healthy controls. Serum levels of interferon γ (IFN-γ), interleukin- (IL-) 1β, and IL-6 were determined quantitatively by ELISA method. Our analysis identified a signature of oxidative stress associated with AA and NSV, characterized by elevated levels of IFN-γ (AA: p=0.007283; NSV: p=0.038467), IL-1β (AA; NSV: p≤0.001), and IL-6 (AA; NSV: p≤0.001). IL-6 was also significantly increased in NSV patients in comparison with AA patients (p=0.004485). Our results supported the hypothesis that oxidative stress may play a significant role in promoting and amplifying the inflammatory process both in AA and vitiligo. The complex understanding of both disease etiopathogenesis involves interrelationships between oxidative stress and autoimmunity. The clinical study registration number is RNN/266/16/KE.

26 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KTKatarzyna Tomaszewska
Katarzyna Tomaszewska
ASAleksandra Słodka
Aleksandra Słodka
BTBartłomiej Tarkowski
Bartłomiej Tarkowski
AZAnna Zalewska-Janowka
Anna Zalewska-Janowka
Urticaria is a condition characterized by the development of itchy wheals (hives), angioedema, or both. The pathophysiology of chronic spontaneous urticaria (CSU) is still poorly understood. It is suggested that there is no dominant and independent mechanism of CSU; however, there are different immunological and non-immunological abnormalities that act simultaneously or/and follow each other resulting in clinical symptoms. The latest hypothesis points out that mast cells (MCs) to be activated via autoantibodies in autoallergic or autoimmune mechanism mediators released from degranulated MCs are responsible for the vasoactive and neurospecific effect in CSU. According to many clinical observations, it is suggested that psychological stress can be both a triggering factor in the onset of CSU and a modulating one in the course of the disease and therapy effectiveness. Of importance, the mechanistic background of the psychological stress response in the skin has not yet been fully elucidated. However, of note, a variety of inflammatory mediators, neuropeptides, and neurotransmitters facilitate this phenomenon. This review presents recent findings on the neuro–immuno–psychological aspects of CSU, highlighting an emerging role of neuro–immune interactions. It also points out the usefulness of psychological tools employment for the baseline diagnosis of perceived stress level and the presence of its symptoms. Furthermore, it proposes the implementation of non-invasive interventions to reduce psychological stress and anxiety. A bio–psycho–social approach including psychological support and patient education seems to be as important as traditional pharmacotherapy for CSU. It facilitates the effective control of active disease and a prolonged remission time in this disease.

Verified
Journal Article
Open access
PDF file
BTBartłomiej Tarkowski
Bartłomiej Tarkowski
JŁJulia Ławniczak
Julia Ławniczak
KTKatarzyna Tomaszewska
Katarzyna Tomaszewska
Marcin KurowskiMarcin Kurowski
Marcin Kurowski
AZAnna Zalewska-Janowka
Anna Zalewska-Janowka
Biomarkers that are able to predict the response to omalizumab (OMA) in chronic spontaneous urticaria (CSU) are highly valued. The aim of our study was to evaluate the UAS7 (urticaria activity score assessed for 7 days), DLQI (dermatology life quality index), SII (systemic immune-inflammation index), SIRI (systemic inflammation response index), PLR (platelet/lymphocyte ratio) and NLR (neutrophil/lymphocyte ratio) in a group of 46 CSU a patients treated for 24 weeks with OMA (300 mg every 4 weeks). There were no statistically significant differences observed at the start nor at the end of the treatment between the two groups (responders vs. non-responders) and SII, SIRI, PLR and NLR. However, a statistically significant correlation was observed between severity of urticaria expressed in UAS7 scores and the quality of life (evaluated by DLQI). Furthermore, at week 24, both groups demonstrated significant improvement in quality of life. Our single center study did not confirm the usefulness of SII, SIRI, NLR or PLR as predictors of the response to OMA in CSU. However, it is of importance that even patients who did not respond to the treatment presented a significant improvement in quality of life. Additionally, we also observed that the efficacy of treatment was unchanged amongst patients who underwent a second series of treatment in cases of relapse.

9 April 2024 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Open access
ICIvan Chérrez-Ojeda
Ivan Chérrez-Ojeda
Jean BousquetJean Bousquet
Jean Bousquet
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau
KGKiran Godse
Kiran Godse
Dorota KrasowskaDorota Krasowska
Dorota Krasowska
MMMarcus Maurer
Marcus Maurer
Patient-reported outcome measures (PROMs) are validated and standardized tools that complement physician evaluations and guide treatment decisions. PROMs are crucial for monitoring atopic dermatitis (AD) and chronic urticaria (CU) in clinical practice, but there are unmet needs and knowledge gaps regarding their use in clinical practice. We investigated the global real-world use of AD and CU PROMs in allergology and dermatology clinics as well as their associated local and regional networks. Across 72 specialized allergy and dermatology centers and their local and regional networks, 2,534 physicians in 73 countries completed a 53-item questionnaire on the use of PROMs for AD and CU. Of 2,534 physicians, 1,308 were aware of PROMs. Of these, 14% and 15% used PROMs for AD and CU, respectively. Half of physicians who use PROMs do so only "rarely" or "sometimes". AD and CU PROM usage is associated with being female, younger, and a dermatologist. POSCORAD and UAS were the most utilized PROMs for AD and CU, respectively. Monitoring disease control and activity are the main drivers of the use of PROMs. Time constraints were the primary obstacle to using PROMs, followed by the impression that patients dislike PROMs. AD and CU PROM users would like training in selecting the proper PROM. Even though PROMs offer several benefits, their use in routine practice is suboptimal, and physicians perceive barriers to their use. It is essential to attain higher levels of PROM implementation in accordance with national and international standards.

1 January 2022 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
PDF file
KTKatarzyna Tomaszewska
Katarzyna Tomaszewska
MKMagdalena Kozłowska
Magdalena Kozłowska
AKAndrzej Kaszuba
Andrzej Kaszuba
ALAleksandra Lesiak
Aleksandra Lesiak
JNJoanna Narbutt
Joanna Narbutt
AZAnna M. Zalewska-Janowska
Anna M. Zalewska-Janowska
Introduction Alopecia areata (AA) and vitiligo are both skin diseases of autoimmune origin. AA is characterized by patchy hair loss primarily on the scalp but may involve other areas as well, while vitiligo is caused by the destruction of melanocytes and results in the appearance of white...

10 May 2024 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Open access
ICIvan Chérrez-Ojeda
Ivan Chérrez-Ojeda
Jean BousquetJean Bousquet
Jean Bousquet
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau
KGKiran Godse
Kiran Godse
Dorota KrasowskaDorota Krasowska
Dorota Krasowska
MMMarcus Maurer
Marcus Maurer